These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
164 related articles for article (PubMed ID: 37125227)
21. Hamdi AM; Fida M; Abu Saleh OM; Beam E Open Forum Infect Dis; 2020 Jan; 7(1):ofaa008. PubMed ID: 32016126 [TBL] [Abstract][Full Text] [Related]
22. In vitro activities of cefiderocol, ceftolozane/tazobactam, ceftazidime/avibactam and other comparative drugs against imipenem-resistant Pseudomonas aeruginosa and Acinetobacter baumannii, and Stenotrophomonas maltophilia, all associated with bloodstream infections in Taiwan. Hsueh SC; Lee YJ; Huang YT; Liao CH; Tsuji M; Hsueh PR J Antimicrob Chemother; 2019 Feb; 74(2):380-386. PubMed ID: 30357343 [TBL] [Abstract][Full Text] [Related]
25. Characterization of Phenotypic and Genotypic Diversity of Bostanghadiri N; Ghalavand Z; Fallah F; Yadegar A; Ardebili A; Tarashi S; Pournajaf A; Mardaneh J; Shams S; Hashemi A Front Microbiol; 2019; 10():1191. PubMed ID: 31191502 [No Abstract] [Full Text] [Related]
26. Treatment of recurrent Stenotrophomonas maltophilia ventilator-associated pneumonia with doxycycline and aerosolized colistin. Wood GC; Underwood EL; Croce MA; Swanson JM; Fabian TC Ann Pharmacother; 2010 Oct; 44(10):1665-8. PubMed ID: 20736426 [TBL] [Abstract][Full Text] [Related]
27. Can levofloxacin be a useful alternative to trimethoprim-sulfamethoxazole for treating Stenotrophomonas maltophilia bacteremia? Cho SY; Kang CI; Kim J; Ha YE; Chung DR; Lee NY; Peck KR; Song JH Antimicrob Agents Chemother; 2014; 58(1):581-3. PubMed ID: 24126583 [TBL] [Abstract][Full Text] [Related]
28. Risk factors for infections with multidrug-resistant Stenotrophomonas maltophilia in patients with cancer. Ansari SR; Hanna H; Hachem R; Jiang Y; Rolston K; Raad I Cancer; 2007 Jun; 109(12):2615-22. PubMed ID: 17487860 [TBL] [Abstract][Full Text] [Related]
29. Distribution of Class 1 Integrons, sul1 and sul2 Genes Among Clinical Isolates of Stenotrophomonas maltophilia from a Tertiary Care Hospital in North India. Kaur P; Gautam V; Tewari R Microb Drug Resist; 2015 Aug; 21(4):380-5. PubMed ID: 25781206 [TBL] [Abstract][Full Text] [Related]
30. Prevalence and Antibiotic Resistance of Gajdács M; Urbán E Health Serv Res Manag Epidemiol; 2019; 6():2333392819870774. PubMed ID: 31453265 [TBL] [Abstract][Full Text] [Related]
31. Cefiderocol: A Siderophore Cephalosporin with Activity Against Carbapenem-Resistant and Multidrug-Resistant Gram-Negative Bacilli. Zhanel GG; Golden AR; Zelenitsky S; Wiebe K; Lawrence CK; Adam HJ; Idowu T; Domalaon R; Schweizer F; Zhanel MA; Lagacé-Wiens PRS; Walkty AJ; Noreddin A; Lynch Iii JP; Karlowsky JA Drugs; 2019 Feb; 79(3):271-289. PubMed ID: 30712199 [TBL] [Abstract][Full Text] [Related]
32. Comparison of different antimicrobial susceptibility testing methods for Stenotrophomonas maltophilia and results of synergy testing. Gülmez D; Cakar A; Sener B; Karakaya J; Hasçelik G J Infect Chemother; 2010 Oct; 16(5):322-8. PubMed ID: 20449623 [TBL] [Abstract][Full Text] [Related]
33. Risk Factors for Mortality in Hospitalized Patients with Jian J; Xie Z; Chen L Infect Drug Resist; 2022; 15():3881-3886. PubMed ID: 35903579 [TBL] [Abstract][Full Text] [Related]
35. Cefiderocol as a Treatment Option for Stenotrophomonas maltophilia Causing Hospital-Acquired/Ventilator-Associated Pneumonia. Rashid MH; Bukhari SNY; Mousa A; Aziz AA; Hakobyan K Cureus; 2023 May; 15(5):e38613. PubMed ID: 37284369 [TBL] [Abstract][Full Text] [Related]
36. First case of persistent Stenotrophomonas maltophilia bacteraemia due to septic thrombosis successfully treated with a cefiderocol-containing regimen. Medioli F; Casali E; Viscido A; Pistolesi V; Venditti M; Oliva A J Glob Antimicrob Resist; 2023 Sep; 34():5-8. PubMed ID: 37307950 [TBL] [Abstract][Full Text] [Related]
37. Medical Management of Endocarditis Caused by Shah S; King M; Rose L J Pharm Pract; 2019 Dec; 32(6):683-686. PubMed ID: 29575970 [TBL] [Abstract][Full Text] [Related]
38. Comparisons between patients with trimethoprim-sulfamethoxazole-susceptible and trimethoprim-sulfamethoxazole-resistant Stenotrophomonas maltophilia monomicrobial bacteremia: A 10-year retrospective study. Wang CH; Lin JC; Lin HA; Chang FY; Wang NC; Chiu SK; Lin TY; Yang YS; Kan LP; Yang CH; Chan MC; Yeh KM J Microbiol Immunol Infect; 2016 Jun; 49(3):378-86. PubMed ID: 25081988 [TBL] [Abstract][Full Text] [Related]
39. Activity of Potential Alternative Treatment Agents for Stenotrophomonas maltophilia Isolates Nonsusceptible to Levofloxacin and/or Trimethoprim-Sulfamethoxazole. Biagi M; Tan X; Wu T; Jurkovic M; Vialichka A; Meyer K; Mendes RE; Wenzler E J Clin Microbiol; 2020 Jan; 58(2):. PubMed ID: 31748318 [No Abstract] [Full Text] [Related]
40. A multicenter surveillance of antimicrobial resistance on Stenotrophomonas maltophilia in Taiwan. Wu H; Wang JT; Shiau YR; Wang HY; Lauderdale TL; Chang SC; J Microbiol Immunol Infect; 2012 Apr; 45(2):120-6. PubMed ID: 22154599 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]